315 related articles for article (PubMed ID: 30408543)
1. An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs.
Huang D; Cui L; Ahmed S; Zainab F; Wu Q; Wang X; Yuan Z
Food Chem Toxicol; 2019 Jan; 123():574-594. PubMed ID: 30408543
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
Chistiakov DA; Orekhov AN; Bobryshev YV
Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of active Chinese herbal components for cancer prevention and treatment: A follow-up review.
Huang Z; Huang Q; Ji L; Wang Y; Qi X; Liu L; Liu Z; Lu L
Pharmacol Res; 2016 Dec; 114():1-12. PubMed ID: 27697644
[TBL] [Abstract][Full Text] [Related]
4. Epi-drugs as triple-negative breast cancer treatment.
Idrissou M; Sanchez A; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
Epigenomics; 2020 Apr; 12(8):725-742. PubMed ID: 32396394
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic effects of metformin: From molecular mechanisms to clinical implications.
Bridgeman SC; Ellison GC; Melton PE; Newsholme P; Mamotte CDS
Diabetes Obes Metab; 2018 Jul; 20(7):1553-1562. PubMed ID: 29457866
[TBL] [Abstract][Full Text] [Related]
6. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
Eglen RM; Reisine T
J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
[TBL] [Abstract][Full Text] [Related]
7. Natural Compounds: Role in Reversal of Epigenetic Changes.
Aggarwal R; Jha M; Shrivastava A; Jha AK
Biochemistry (Mosc); 2015 Aug; 80(8):972-89. PubMed ID: 26547065
[TBL] [Abstract][Full Text] [Related]
8. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
Sankrityayan H; Kulkarni YA; Gaikwad AB
Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
[TBL] [Abstract][Full Text] [Related]
9. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
Valdespino-Gómez VM; Valdespino-Castillo VE
Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
[TBL] [Abstract][Full Text] [Related]
10. Histone methyltransferase inhibitors: novel epigenetic agents for cancer treatment.
Zagni C; Chiacchio U; Rescifina A
Curr Med Chem; 2013; 20(2):167-85. PubMed ID: 23210854
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic agents in combined anticancer therapy.
Kejík Z; Jakubek M; Kaplánek R; Králová J; Mikula I; Martásek P; Král V
Future Med Chem; 2018 May; 10(9):1113-1130. PubMed ID: 29676175
[TBL] [Abstract][Full Text] [Related]
12. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.
Cacabelos R
Drug Dev Res; 2014 Sep; 75(6):348-65. PubMed ID: 25195579
[TBL] [Abstract][Full Text] [Related]
13. [Development of novel epigenetic molecular-targeting agents].
Sowa Y; Sakai T
Nihon Rinsho; 2015 Aug; 73(8):1263-7. PubMed ID: 26281676
[TBL] [Abstract][Full Text] [Related]
14. Involvement of epigenetics and microRNA-29b in the urethane induced inception and establishment of mouse lung tumors.
Pandey M; Sultana S; Gupta KP
Exp Mol Pathol; 2014 Feb; 96(1):61-70. PubMed ID: 24361357
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
[TBL] [Abstract][Full Text] [Related]
16. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.
Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L
Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760
[TBL] [Abstract][Full Text] [Related]
17. Human DNA (cytosine-5)-methyltransferases: a functional and structural perspective for epigenetic cancer therapy.
Rondelet G; Wouters J
Biochimie; 2017 Aug; 139():137-147. PubMed ID: 28600135
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic targeting in pancreatic cancer.
van Kampen JG; Marijnissen-van Zanten MA; Simmer F; van der Graaf WT; Ligtenberg MJ; Nagtegaal ID
Cancer Treat Rev; 2014 Jun; 40(5):656-64. PubMed ID: 24433955
[TBL] [Abstract][Full Text] [Related]
19. Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA.
Szczepanek J; Skorupa M; Jarkiewicz-Tretyn J; Cybulski C; Tretyn A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108398
[TBL] [Abstract][Full Text] [Related]
20. Beyond regulations at DNA levels: A review of epigenetic therapeutics targeting cancer stem cells.
Zhang S; Gong Y; Li C; Yang W; Li L
Cell Prolif; 2021 Feb; 54(2):e12963. PubMed ID: 33314500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
